Logo image
Lysosomes and the pathogenesis of merosin-deficient congenital muscular dystrophy
Journal article   Open access   Peer reviewed

Lysosomes and the pathogenesis of merosin-deficient congenital muscular dystrophy

Sarah J Smith, Lacramioara Fabian, Adeel Sheikh, Ramil Noche, Xiucheng Cui, Steven A Moore and James J Dowling
Human molecular genetics, Vol.31(5), pp.733-747
09/25/2021
DOI: 10.1093/hmg/ddab278
PMCID: PMC9989739
PMID: 34568901
url
https://doi.org/10.1093/hmg/ddab278View
Published (Version of record) Open Access

Abstract

Abstract Congenital muscular dystrophy type 1A (MDC1A), the most common congenital muscular dystrophy in Western countries, is caused by recessive mutations in LAMA2, the gene encoding laminin alpha 2. Currently, no cure or disease modifying therapy has been successfully developed for MDC1A. Examination of patient muscle biopsies revealed altered distribution of lysosomes. We hypothesized that this redistribution was a novel and potentially druggable aspect of disease pathogenesis. We explored this hypothesis using candyfloss (caf), a zebrafish model of MDC1A. We found that lysosome distribution in caf zebrafish was also abnormal. This altered localization was significantly associated with fiber detachment and could be prevented by blocking myofiber detachment. Overexpression of transcription factor EB, a transcription factor that promotes lysosomal biogenesis, led to increased lysosome content and decreased fiber detachment. We conclude that genetic manipulation of the lysosomal compartment is able to alter the caf zebrafish disease process, suggesting that lysosome function may be a target for disease modification.

Details

Metrics

Logo image